International Business Machines Corporation (NYSE:IBM) has renewed efforts to sell IBM Watson Health, Inc. and looks to fetch more than $1 billion for the unit, Axios' Sarah Pringle reports, citing people familiar with the matter. IBM first explored a sale of the division in early 2021, with Morgan Stanley leading the process, and engaged BofA Securities in late 2021 to find a buyer for the unit. According to one source, bids were due on January 04, 2022, and IBM looks to select the winner by the end of January 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
165.9 USD | +0.76% | -0.65% | +1.52% |
04:43pm | Intesa targets new digital-only clients after antritrust blow | RE |
May. 02 | IBM Expands Software Availability on Amazon's AWS Marketplace | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.52% | 151B | |
-13.48% | 189B | |
+1.32% | 167B | |
+3.60% | 99.18B | |
+21.04% | 73.42B | |
-8.21% | 70.16B | |
-20.31% | 52.69B | |
-8.05% | 44.15B | |
+7.34% | 36.51B | |
-11.91% | 32.99B |
- Stock Market
- Equities
- IBM Stock
- News IBM
- IBM Reportedly Renews Efforts to Sell Watson Health, Looks to Fetch over $1Billion